HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$3.59
Day range
$3.10 - $3.62
Year range
$2.87 - $13.70
Market cap
174.76M USD
Avg Volume
414.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | -100.00% |
Operating expense | 7.72M | -21.78% |
Net income | -16.57M | 33.07% |
Net profit margin | — | — |
Earnings per share | -0.31 | 22.50% |
EBITDA | -19.06M | 30.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 241.02M | 2.03% |
Total assets | 260.72M | 1.17% |
Total liabilities | 17.68M | -21.41% |
Total equity | 243.03M | — |
Shares outstanding | 53.98M | — |
Price to book | 0.80 | — |
Return on assets | -18.00% | — |
Return on capital | -18.75% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -16.57M | 33.07% |
Cash from operations | -16.76M | 27.62% |
Cash from investing | 2.26M | -87.69% |
Cash from financing | 83.00K | -71.08% |
Net change in cash | -14.42M | -219.19% |
Free cash flow | -11.69M | 19.01% |
About
Founded
2015
Website
Employees
45
